Nurse-led hepatocellular carcinoma surveillance clinic provides an effective method of monitoring patients with cirrhosis

被引:18
作者
Nazareth, Saroj [1 ,2 ]
Leembruggen, Nadine [1 ,2 ]
Tuma, Rhoda [1 ,2 ]
Chen, Sook-Ling [1 ,2 ]
Rao, Samarth [1 ,2 ]
Kontorinis, Nick [1 ,2 ]
Cheng, Wendy [1 ,2 ]
机构
[1] Royal Perth Hosp, Dept Gastroenterol & Hepatol, Level 4 South Block,Wellington St, Perth, WA 6000, Australia
[2] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia
关键词
cirrhosis; HCC screening; hepatocellular carcinoma; nurse-led programme; surveillance; HEPATITIS-C; ETIOLOGY;
D O I
10.1111/ijn.12472
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The aim of this study is to examine the acceptability and effectiveness of a nurse-led hepatocellular carcinoma (HCC) surveillance clinic in high-risk patients with cirrhosis/advanced fibrosis. Early detection of HCC is associated with better treatment outcomes and improved survival. International guidelines recommend 6-monthly surveillance of patients at risk of developing HCC. A nurse-led HCC surveillance protocol was established to support patients in adherence to surveillance protocols. The design used was retrospective document analysis. Retrospective analysis of healthcare records of patients referred to the clinic between August 2009 and December 2015. Extracted data included attendance of clinic visits, blood testing, ultrasound or other imaging, and outcomes. Ultrasound was attended within 6months in 30.3% of cases and within 7months in 71.2% of cases. The median time between Nurse-Led Clinic appointments, ultrasound scans and blood testing did not exceed 9months. First year FibroScans were attended by 82.9% (63/76) patients; endoscopy was indicated for 42 and attended by 35 (83.3%) patients. Lesions were identified in 16 patients (21.5%) and HCC diagnosed in two patients. One patient died because of HCC and one to sub-dural haematoma. Nurse-led HCC surveillance was an effective method of monitoring patients with cirrhosis at high risk of developing HCC. Well-defined protocols enable timely identification of patients with HCC or hepatic decompensation so that management strategies can be implemented without delay. The potential benefits identified by this study warrant further, rigorous evaluation.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 24 条
[1]  
Abe Ryo, 2012, Nihon Shokakibyo Gakkai Zasshi, V109, P741
[2]   The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis [J].
Ascha, Mustafa S. ;
Hanouneh, Ibrahim A. ;
Lopez, Rocio ;
Tamimi, Tarek Abu-Rajab ;
Feldstein, Ariel F. ;
Zein, Nizar N. .
HEPATOLOGY, 2010, 51 (06) :1972-1978
[3]   Management of Hepatocellular Carcinoma: An Update [J].
Bruix, Jordi ;
Sherman, Morris .
HEPATOLOGY, 2011, 53 (03) :1020-1022
[4]   Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis [J].
Cardoso, Ana-Carolina ;
Moucari, Rami ;
Figueiredo-Mendes, Claudio ;
Ripault, Marie-Pierre ;
Giuily, Nathalie ;
Castelnau, Corinne ;
Boyer, Nathalie ;
Asselah, Tarik ;
Martinot-Peignoux, Michelle ;
Maylin, Sarah ;
Carvalho-Filho, Roberto J. ;
Valla, Dominique ;
Bedossa, Pierre ;
Marcellin, Patrick .
JOURNAL OF HEPATOLOGY, 2010, 52 (05) :652-657
[5]   Utilization of screening for hepatocellular carcinoma in the United States [J].
Davila, Jessica A. ;
Weston, Allan ;
Smalley, Walter ;
El-Serag, Hashem B. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (08) :777-782
[6]   Use of Surveillance for Hepatocellular Carcinoma Among Patients With Cirrhosis in the United States [J].
Davila, Jessica A. ;
Morgan, Robert O. ;
Richardson, Peter A. ;
Du, Xianglin L. ;
McGlynn, Katherine A. ;
El-Serag, Hashem B. .
HEPATOLOGY, 2010, 52 (01) :132-141
[7]   Association Between Hepatitis C and Hepatocellular Carcinoma [J].
de Oliveira Andrade, Luis Jesuino ;
D'Oliveira Junior, Argemiro ;
Melo, Rosangela Carvalho ;
De Souza, Emmanuel Conrado ;
Costa Silva, Carolina Alves ;
Parana, Raymundo .
JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2009, 1 (01) :33-37
[8]   Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice? [J].
Edenvik, Pia ;
Davidsdottir, Loa ;
Oksanen, Antti ;
Isaksson, Bengt ;
Hultcrantz, Rolf ;
Stal, Per .
LIVER INTERNATIONAL, 2015, 35 (07) :1862-1871
[9]   Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients With Commercial Health Insurance [J].
Goldberg, David S. ;
Valderrama, Adriana ;
Kamalakar, Rajesh ;
Sansgiry, Sujit S. ;
Babajanyan, Svetlana ;
Lewis, James D. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 (03) :258-265
[10]  
Henrion J, 2000, ACTA GASTRO-ENT BELG, V63, P5